US FDA expands approval for J&J's drug for rare blood disorder

Aug 24 (Reuters) – The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug to treat a rare blood disorder, the company said on Monday. (Reporting by Kunal Das

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)